Lipid peroxidation (LPO) is a free radical-related process that in bio
logic systems may occur under enzymatic control, e.g., for the generat
ion of lipid-derived inflammatory mediators, or nonenzymatically. This
latter form is associated mostly with cellular damage as a result of
oxidative stress, which also involves cellular antioxidants in this pr
ocess. This article focuses on the relevance of two LPO products, malo
ndialdehyde (MDA) and 4-hydroxynonenal (HNE), to the pathophysiology o
f human disease. The former has been studied in human serum samples of
hepatitis C virus-infected adults and human immunodeficiency virus-in
fected children. In these two cases it is shown that the specific assa
y of serum MDA is useful for the clinical management of these patients
. The presence of MDA in subretinal fluid of patients with retinal det
achment suggests the involvement of oxidative stress in this process.
Moreover, we were able to report the dependence of this involvement on
the degree of myopia in these patients. The assay of MDA contents in
the peripheral nerves of rats fed a chronic alcohol-containing diet or
diabetic mice also confirms the pathophysiologic role of oxidative st
ress in these experimental models. In these two cases, associated with
an increase in tissue LPO products content, we detected a decrease of
glutathione peroxidase (GSHPx) activity in peripheral nerve, among ot
her modifications. We have demonstrated that in vitro HNE is able to i
nhibit GSHPx activity in an apparent competitive manner, and that glut
athione may partially protect and/or prevent this inactivation. The ac
cumulation of LPO products in the brain of patients with Alzheimer's d
isease has also been described, and it is on the basis of this observa
tion that we have tried to elucidate the role of oxidative stress and
cellular antioxidants in beta-amyloid-induced apoptotic cell death of
rat embryo neurons. Finally, we discuss the possible role of the obser
ved vascular effects of HNE on human arteries.